Detalhe da pesquisa
1.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
N Engl J Med
; 389(4): 335-347, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272512
2.
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
Br J Haematol
; 204(3): 887-891, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054558
3.
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Haematologica
; 109(3): 906-914, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646658
4.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021929
5.
Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies.
Br J Haematol
; 197(1): 28-40, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671973
6.
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy.
Am J Hematol
; 97(9): 1170-1177, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731911
7.
Exploring health behaviors and the feasibility of a lifestyle intervention for patients with multiple myeloma.
Support Care Cancer
; 30(12): 9771-9779, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36287278
8.
Rap1A, Rap1B, and ß-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol.
Yale J Biol Med
; 95(1): 45-56, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370486
9.
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Cancer
; 127(1): 82-92, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966625
10.
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.
Biol Blood Marrow Transplant
; 26(12): 2229-2236, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920204
11.
Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.
Biol Blood Marrow Transplant
; 26(11): 2011-2017, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717431
12.
Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.
Biol Blood Marrow Transplant
; 26(7): 1288-1297, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135202
13.
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes.
Biol Blood Marrow Transplant
; 26(5): 893-901, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31982543
14.
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(10): 1876-1885, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653622
15.
Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials.
Cancer
; 126(12): 2791-2801, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154922
16.
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
Br J Haematol
; 191(3): 442-452, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094839
17.
Trends in the use of therapeutic plasma exchange in multiple myeloma.
J Clin Apher
; 35(4): 307-315, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516865
18.
Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome.
Biol Blood Marrow Transplant
; 25(5): 921-931, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537549
19.
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(8): 1492-1497, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959163
20.
Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.
Biol Blood Marrow Transplant
; 25(4): 827-833, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30572109